SSRI治疗对既往抑郁的轻度认知障碍患者向阿尔茨海默病痴呆转化的影响
该研究基于阿尔茨海默病神经影像学倡议的755名当前无抑郁参与者数据,评估SSRI治疗对脑脊液生物标志物及从轻度认知障碍(MCI)向阿尔茨海默病痴呆进展的影响。结果显示,在有抑郁史的MCI患者中,长期SSRI治疗(>4年)与阿尔茨海默病痴呆进展延迟约3年显著相关,但各治疗组间脑脊液生物标志物水平无差异。
要点
- 有抑郁史的MCI患者中,长期SSRI治疗(>4年)与痴呆进展延迟约3年相关。
- 长期SSRI治疗与短期SSRI、其他抗抑郁药或无治疗相比,延迟进展关联显著。
- 各治疗组间脑脊液生物标志物水平未观察到差异。
核心结论
- 长期SSRI治疗可能延迟有抑郁史的MCI患者向阿尔茨海默病痴呆的进展。
研究设计与样本
- 评估了来自纵向阿尔茨海默病神经影像学倡议的755名当前无抑郁参与者的数据集。
- 采用Kaplan-Meier分析及以ApoE4状态和年龄为协变量的方差与协方差分析。
主要发现
- 在有抑郁史的MCI患者中,长期SSRI治疗(>4年)与阿尔茨海默病痴呆进展延迟约3年显著相关。
- 该关联见于与短期SSRI治疗、其他抗抑郁药治疗或无治疗的比较,以及与无抑郁史MCI患者的比较。
- 各治疗组间脑脊液生物标志物水平未观察到差异。
临床怎么用
- 对当前无抑郁但有抑郁史的MCI患者,可考虑长期SSRI治疗以可能延迟痴呆进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Depression is associated with an increased risk of Alzheimer's disease. Research has shown that the selective serotonin reuptake inhibitor (SSRI) citalopram decreases amyloid-β generation and plaque load. The authors evaluated the impact of SSRI treatment on CSF biomarkers and progression from mild cognitive impairment (MCI) to Alzheimer's dementia. METHOD: Data sets from 755 currently nondepressed participants from the longitudinal Alzheimer's Disease Neuroimaging Initiative were evaluated by Kaplan-Meier analysis and analyses of variance and covariance with ApoE4 status and age as covariates. RESULTS: In MCI patients with a history of depression, long-term SSRI treatment (>4 years) was significantly associated with a delayed progression to Alzheimer's dementia by approximately 3 years, compared with short-term SSRI treatment, treatment with other antidepressants, or no treatment and compared with MCI patients without a history of depression. No differences in CSF biomarker levels were observed between treatment groups. CONCLUSIONS: Long-term SSRI treatment may delay progression from MCI to Alzheimer's dementia.
引用
- Bartels C, Wagner M, Wolfsgruber S, et al. Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression. Am J Psychiatry. 2017. PMID: 29179578. doi:10.1176/appi.ajp.2017.17040404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。